{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:00:07Z","timestamp":1793412007187,"version":"4.5.0"},"reference-count":75,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Short courses of systemic corticosteroids are used in the management of a number of acute clinical conditions, including Bell palsy, croup, and pneumonia, but research on associations of corticosteroid use with adverse events (AEs) in children is limited.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To document AEs associated with short-term (\u226414 days) use of systemic corticosteroids in children and adolescents (1 to younger than 18 years) across different clinical conditions.<\/jats:p>\n <\/jats:sec>\n \n Data Sources<\/jats:title>\n MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) databases were searched from inception to February 2025. Reference lists of eligible articles and related systematic reviews were also searched.<\/jats:p>\n <\/jats:sec>\n \n Study Selection<\/jats:title>\n Randomized clinical trials evaluating AEs (any unfavorable and unintended signs, symptoms, or syndromes that occurred during the period of using an investigational product) after use of short-course systemic corticosteroids in children and adolescents were included.<\/jats:p>\n <\/jats:sec>\n \n Data Extraction and Synthesis<\/jats:title>\n Using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses reporting guideline, pairs of reviewers independently reviewed abstracts, extracted data, and assessed risk of bias of eligible trials. Pairwise, fixed-effects meta-analyses were performed using Mantel-Haenszel methods with risk difference (RD).<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcomes were serious AEs (events resulting in death, life-threatening conditions, hospitalization, or substantial disability), AEs leading to discontinuation, hyperglycemia, sleep disturbances, change in behavior, and gastrointestinal bleeding. RDs were reported as AEs per 1000 patients with 95% CIs. The Grading of Recommendations Assessment, Development and Evaluation approach was used to assess the certainty of evidence (high, moderate, low, or very low certainty).<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A total of 45 eligible trials that included 6470 children (mean [SD] age, 5.57 [3.62] years; 3753 male [58%]) were identified. In pooled analysis, there was moderate certainty evidence that compared with usual care, corticosteroids were not associated with serious AEs (RD, 1 fewer AE per 1000 patients [95% CI], 9 fewer to 7 more AEs per 1000 patients]), AEs leading to discontinuation (RD, 4 more AEs per 1000 patients [95% CI, 3 fewer to 11 more AEs per 1000 patients]), or change in behavior (RD, 8 more AEs per 1000 patients [95% CI, 5 fewer to 21 more AEs per 1000 patients]). With moderate certainty evidence, corticosteroids were associated with an increased risk of hyperglycemia (RD, 38 more AEs per 1000 patients [95% CI, 11 to 64 more AEs per 1000 patients]) and sleep problems (RD, 15 more AEs per 1000 patients [95% CI, 1 to 28 more AEs per 1000 patients]). Corticosteroid use was also associated with an increased risk of gastrointestinal bleeding (RD, 13 more per AEs per 1000 patients [95% CI, 3 to 23 more AEs per 1000 patients]), but the certainty of evidence was low.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this systematic review and meta-analysis of randomized trials, there was moderate certainty evidence that corticosteroids were associated with an increased risk of hyperglycemia and sleep problems and low certainty evidence that corticosteroids were associated with increased risk of gastrointestinal bleeding, but these AEs were very seldom serious. These findings suggest that an individualized approach to short-term corticosteroid use may be warranted and that further research is needed to obtain better quality of evidence.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.34953","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T15:30:41Z","timestamp":1759246241000},"page":"e2534953","source":"Crossref","is-referenced-by-count":24,"title":["Adverse Events Following Short-Course Systemic Corticosteroids Among Children and Adolescents"],"prefix":"10.1001","volume":"8","author":[{"given":"Jo\u00e3o Pedro","family":"Lima","sequence":"first","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saifur R.","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Michael G. DeGroote Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wimonchat","family":"Tangamornsuksan","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjuan","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Shandong Provincial Hospital, Shandong First Medical University, Jinan, Shandong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiajing","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessyca","family":"Matos Silva","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humayun","family":"Kabir","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Public Health, North South University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmudur Rahman","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Department of Public Health, North South University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Couban","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Walsh","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Rochwerg","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Eltorki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Pediatrics, Cumming School of Medicine, University of Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon H.","family":"Guyatt","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"},{"name":"MAGIC Evidence Ecosystem Foundation, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"},{"name":"Department of Medicine, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"7","key":"zoi250976r1","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.jaip.2024.04.016","article-title":"Efficacy and safety of systemic corticosteroids for urticaria: a systematic review and meta-analysis of randomized clinical trials.","volume":"12","author":"Chu","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"9","key":"zoi250976r2","first-page":"575","article-title":"Croup: diagnosis and management.","volume":"97","author":"Smith","year":"2018","journal-title":"Am Fam Physician"},{"issue":"6","key":"zoi250976r3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/00006565-199412000-00008","article-title":"A controlled trial of methylprednisolone in the early emergency department treatment of acute asthma in children.","volume":"10","author":"Wolfson","year":"1994","journal-title":"Pediatr Emerg Care"},{"issue":"2","key":"zoi250976r4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/ijms20020444","article-title":"Clinical use and molecular action of corticosteroids in the pediatric age.","volume":"20","author":"Ferrara","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"8","key":"zoi250976r6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028511","article-title":"Safety of corticosteroids in young children with acute respiratory conditions: a systematic review and meta-analysis.","volume":"9","author":"Fernandes","year":"2019","journal-title":"BMJ Open"},{"issue":"4","key":"zoi250976r7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/archdischild-2015-309522","article-title":"Systematic review of the toxicity of short-course oral corticosteroids in children.","volume":"101","author":"Aljebab","year":"2016","journal-title":"Arch Dis Child"},{"issue":"2","key":"zoi250976r8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033567","article-title":"Economic evaluation of the OSAC randomised controlled trial: oral corticosteroids for non-asthmatic adults with acute lower respiratory tract infection in primary care.","volume":"10","author":"Moure-Fernandez","year":"2020","journal-title":"BMJ Open"},{"issue":"1","key":"zoi250976r9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s12325-024-03024-3","article-title":"Oral corticosteroid-related healthcare resource utilization and associated costs in patients with COPD.","volume":"42","author":"Tse","year":"2025","journal-title":"Adv Ther"},{"issue":"9","key":"zoi250976r10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003436","article-title":"Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension.","volume":"3","author":"Hodkinson","year":"2013","journal-title":"BMJ Open"},{"key":"zoi250976r11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1471-2288-7-32","article-title":"Systematic reviews of adverse effects: framework for a structured approach.","volume":"7","author":"Loke","year":"2007","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"zoi250976r12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011825.pub2","article-title":"Adverse events in people taking macrolide antibiotics versus placebo for any indication.","volume":"1","author":"Hansen","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"71","key":"zoi250976r13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"zoi250976r14","doi-asserted-by":"publisher","first-page":"i157","DOI":"10.1136\/bmj.i157","article-title":"PRISMA harms checklist: improving harms reporting in systematic reviews.","volume":"352","author":"Zorzela","year":"2016","journal-title":"BMJ"},{"issue":"12","key":"zoi250976r15","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1080\/02770903.2018.1539100","article-title":"A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma.","volume":"56","author":"Al Efraij","year":"2019","journal-title":"J Asthma"},{"key":"zoi250976r17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jclinepi.2021.02.012","article-title":"A proposed framework to guide evidence synthesis practice for meta-analysis with zero-events studies.","volume":"135","author":"Xu","year":"2021","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"zoi250976r18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0002-9343(77)90233-9","article-title":"Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function.","volume":"63","author":"Meikle","year":"1977","journal-title":"Am J Med"},{"issue":"32","key":"zoi250976r20","doi-asserted-by":"publisher","first-page":"E901","DOI":"10.1503\/cmaj.200077","article-title":"Development of the instrument to assess the credibility of effect modification analyses (ICEMAN) in randomized controlled trials and meta-analyses.","volume":"192","author":"Schandelmaier","year":"2020","journal-title":"CMAJ"},{"key":"zoi250976r21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","article-title":"GRADE guidance 34: update on rating imprecision using a minimally contextualized approach.","volume":"150","author":"Zeng","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"zoi250976r22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions.","volume":"119","author":"Santesso","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"20","key":"zoi250976r24","doi-asserted-by":"publisher","first-page":"e2241","DOI":"10.1212\/WNL.0000000000201164","article-title":"Efficacy of prednisolone for Bell palsy in children: a randomized, double-blind, placebo-controlled, multicenter trial.","volume":"99","author":"Babl","year":"2022","journal-title":"Neurology"},{"issue":"9","key":"zoi250976r25","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1182\/blood.V92.9.3082","article-title":"Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease.","volume":"92","author":"Bernini","year":"1998","journal-title":"Blood"},{"issue":"13","key":"zoi250976r26","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1056\/NEJMoa033534","article-title":"A randomized trial of a single dose of oral dexamethasone for mild croup.","volume":"351","author":"Bjornson","year":"2004","journal-title":"N Engl J Med"},{"issue":"22","key":"zoi250976r27","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1182\/blood.V128.22.868.868","article-title":"A randomized, double-blinded, placebo controlled study of IVIG Vs. IVIG with high dose methylprednisolone in rapidly augmenting platelet counts in childhood ITP.","volume":"128","author":"Carcao","year":"2016","journal-title":"Blood"},{"issue":"3","key":"zoi250976r28","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/adc.70.3.170","article-title":"Prednisolone and salbutamol in the hospital treatment of acute asthma.","volume":"70","author":"Connett","year":"1994","journal-title":"Arch Dis Child"},{"issue":"6","key":"zoi250976r29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1067\/S0022-3476(03)00498-0","article-title":"Oral prednisolone in the acute management of children age 6 to 35 months with viral respiratory infection-induced lower airway disease: a randomized, placebo-controlled trial.","volume":"143","author":"Csonka","year":"2003","journal-title":"J Pediatr"},{"issue":"10","key":"zoi250976r30","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1136\/archdischild-2013-303642","article-title":"Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schonlein Purpura (HSP).","volume":"98","author":"Dudley","year":"2013","journal-title":"Arch Dis Child"},{"issue":"2","key":"zoi250976r31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S2213-2600(18)30008-0","article-title":"Oral prednisolone in preschool children with virus-associated wheeze: a prospective, randomised, double-blind, placebo-controlled trial.","volume":"6","author":"Foster","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"10147","key":"zoi250976r32","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0140-6736(18)31490-9","article-title":"Oral steroids for resolution of otitis media with effusion in children (OSTRICH): a double-blinded, placebo-controlled randomised trial.","volume":"392","author":"Francis","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"zoi250976r33","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJM199403173301101","article-title":"High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease.","volume":"330","author":"Griffin","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi250976r34","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1097\/BPO.0b013e3182092869","article-title":"Dexamethasone therapy for septic arthritis in children: results of a randomized double-blind placebo-controlled study.","volume":"31","author":"Harel","year":"2011","journal-title":"J Pediatr Orthop"},{"issue":"2","key":"zoi250976r35","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/infdis\/158.2.325","article-title":"High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial.","volume":"158","author":"Hoffman","year":"1988","journal-title":"J Infect Dis"},{"issue":"4","key":"zoi250976r36","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/infdis\/165.4.631","article-title":"Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus.","volume":"165","author":"Hoke","year":"1992","journal-title":"J Infect Dis"},{"key":"zoi250976r37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1741-7015-2-7","article-title":"A randomized, placebo-controlled trial of prednisone in early Henoch Sch\u00f6nlein Purpura [ISRCTN85109383].","volume":"2","author":"Huber","year":"2004","journal-title":"BMC Med"},{"issue":"4","key":"zoi250976r38","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1399-3038.2007.00512.x","article-title":"Efficacy of prednisolone in children hospitalized for recurrent wheezing.","volume":"18","author":"Jartti","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"issue":"8","key":"zoi250976r39","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1056\/NEJM199808203390802","article-title":"A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup.","volume":"339","author":"Johnson","year":"1998","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi250976r40","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/00006454-199506000-00005","article-title":"Beneficial effects of dexamethasone in children with pneumococcal meningitis.","volume":"14","author":"Kanra","year":"1995","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"zoi250976r41","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1155\/1994\/257198","article-title":"Dexamethasone therapy for bacterial meningitis: better never than late?","volume":"5","author":"King","year":"1994","journal-title":"Can J Infect Dis"},{"issue":"1","key":"zoi250976r42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1651-2227.1988.tb10606.x","article-title":"A randomized double-blind, placebo-controlled trial of dexamethasone and racemic epinephrine in the treatment of croup.","volume":"77","author":"Kuusela","year":"1988","journal-title":"Acta Paediatr Scand"},{"issue":"5","key":"zoi250976r43","first-page":"696","article-title":"Assessment methods of disease activity in juvenile rheumatoid arthritis\u2013evaluated in a prednisolone\/placebo double-blind study.","volume":"9","author":"Kvien","year":"1982","journal-title":"J Rheumatol"},{"issue":"15","key":"zoi250976r44","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1056\/NEJM198810133191502","article-title":"Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials.","volume":"319","author":"Lebel","year":"1988","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi250976r45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0022-3476(79)80821-5","article-title":"A prospective randomized study to determine the efficacy of steroids in treatment of croup.","volume":"94","author":"Leipzig","year":"1979","journal-title":"J Pediatr"},{"issue":"1","key":"zoi250976r46","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1833195","article-title":"Efficacy of methylprednisolone plus azithromycin in the treatment of RMPP and its effect on the changes of t lymphocyte subsets.","volume":"2022","author":"Lv","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"zoi250976r47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-2516.2006.01410.x","article-title":"Short-term oral corticosteroid therapy for acute haemarthrosis in haemophilia patients with high-titer inhibitors.","volume":"13","author":"Medeiros","year":"2007","journal-title":"Haemophilia"},{"issue":"2","key":"zoi250976r48","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ppul.22574","article-title":"Efficacy of methylprednisolone in children with severe community acquired pneumonia.","volume":"48","author":"Nagy","year":"2013","journal-title":"Pediatr Pulmonol"},{"issue":"7","key":"zoi250976r49","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJMoa061235","article-title":"Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.","volume":"356","author":"Newburger","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi250976r50","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1542\/peds.2011-0148","article-title":"Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.","volume":"129","author":"Ogata","year":"2012","journal-title":"Pediatrics"},{"issue":"3","key":"zoi250976r51","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1001\/archpedi.159.3.278","article-title":"Effectiveness of oral dexamethasone in the treatment of moderate to severe pharyngitis in children.","volume":"159","author":"Olympia","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"zoi250976r52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMoa0804897","article-title":"Oral prednisolone for preschool children with acute virus-induced wheezing.","volume":"360","author":"Panickar","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi250976r53","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1542\/peds.54.3.282","article-title":"A double-blind trial of corticosteroid therapy in status asthmaticus.","volume":"54","author":"Pierson","year":"1974","journal-title":"Pediatrics"},{"issue":"5","key":"zoi250976r54","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.seizure.2006.03.003","article-title":"Intravenous methyl prednisolone in patients with solitary cysticercus granuloma: a random evaluation.","volume":"15","author":"Prakash","year":"2006","journal-title":"Seizure"},{"issue":"6","key":"zoi250976r55","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/adc.75.6.482","article-title":"Dexamethasone and bacterial meningitis in Pakistan.","volume":"75","author":"Qazi","year":"1996","journal-title":"Arch Dis Child"},{"key":"zoi250976r56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s40814-020-00671-5","article-title":"Oral prednisolone for acute otitis media in children: a pilot, pragmatic, randomised, open-label, controlled study (OPAL study).","volume":"6","author":"Ranakusuma","year":"2020","journal-title":"Pilot Feasibility Stud"},{"issue":"4","key":"zoi250976r57","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0022-3476(99)70204-0","article-title":"Oral prednisolone is an effective adjuvant therapy for acute otitis media with discharge through tympanostomy tubes.","volume":"134","author":"Ruohola","year":"1999","journal-title":"J Pediatr"},{"issue":"8869","key":"zoi250976r58","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0140-6736(93)91592-A","article-title":"Dexamethasone therapy for bacterial meningitis in children.","volume":"342","author":"Schaad","year":"1993","journal-title":"Lancet"},{"issue":"11","key":"zoi250976r59","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s00467-020-04622-3","article-title":"Corticosteroids to prevent kidney scarring in children with a febrile urinary tract infection: a randomized trial.","volume":"35","author":"Shaikh","year":"2020","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"zoi250976r60","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s12519-017-0014-9","article-title":"Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children.","volume":"13","author":"Shan","year":"2017","journal-title":"World J Pediatr"},{"issue":"6","key":"zoi250976r61","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1067\/mpd.2003.191","article-title":"Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial.","volume":"142","author":"Sundel","year":"2003","journal-title":"J Pediatr"},{"issue":"2","key":"zoi250976r62","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0022-3476(89)80095-2","article-title":"A prospective randomized double-blind study to evaluate the effect of dexamethasone in acute laryngotracheitis.","volume":"115","author":"Super","year":"1989","journal-title":"J Pediatr"},{"key":"zoi250976r63","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jpeds.2017.02.043","article-title":"Dexamethasone for parapneumonic pleural effusion: a randomized, double-blind, clinical trial.","volume":"185","author":"Tagarro","year":"2017","journal-title":"J Pediatr"},{"issue":"9","key":"zoi250976r64","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/cid\/cis655","article-title":"Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial.","volume":"55","author":"Tam","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"zoi250976r65","first-page":"111","article-title":"Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study.","volume":"92","author":"Tassniyom","year":"1993","journal-title":"Pediatrics"},{"issue":"5","key":"zoi250976r66","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S0887-8994(99)00099-5","article-title":"Corticosteroid treatment of childhood Bell\u2019s palsy.","volume":"21","author":"Un\u00fcvar","year":"1999","journal-title":"Pediatr Neurol"},{"issue":"6","key":"zoi250976r67","doi-asserted-by":"publisher","first-page":"E1518","DOI":"10.1542\/peds.2013-3331","article-title":"High doses of methylprednisolone in the management of caustic esophageal burns.","volume":"133","author":"Usta","year":"2014","journal-title":"Pediatrics"},{"issue":"5","key":"zoi250976r68","doi-asserted-by":"publisher","first-page":"850","DOI":"10.31925\/farmacia.2022.5.9","article-title":"The effect of methylprednisolone combined with macrolide antibiotics on Mycoplasma pneumoniae pneumonia in children.","volume":"70","author":"Wang","year":"2022","journal-title":"Farmacia"},{"issue":"4","key":"zoi250976r69","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000001071","article-title":"Adverse effects related to corticosteroid use in sepsis, acute respiratory distress syndrome, and community-acquired pneumonia: a systematic review and meta-analysis.","volume":"6","author":"Chaudhuri","year":"2024","journal-title":"Crit Care Explor"},{"issue":"12","key":"zoi250976r70","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-061476","article-title":"Metabolic adverse events associated with systemic corticosteroid therapy-a systematic review and meta-analysis.","volume":"12","author":"Kulkarni","year":"2022","journal-title":"BMJ Open"},{"issue":"7","key":"zoi250976r71","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/jamapediatrics.2021.0433","article-title":"Association of oral corticosteroid bursts with severe adverse events in children.","volume":"175","author":"Yao","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"9","key":"zoi250976r72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004405.pub5","article-title":"Corticosteroids for acute bacterial meningitis.","volume":"2015","author":"Brouwer","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"zoi250976r74","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/pch\/19.3.141","article-title":"Guidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than one month of age.","volume":"19","author":"Le Saux","year":"2014","journal-title":"Paediatr Child Health"},{"issue":"1","key":"zoi250976r75","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5346819","article-title":"How safe are common analgesics for the treatment of acute pain for children? A systematic review.","volume":"2016","author":"Hartling","year":"2016","journal-title":"Pain Res Manag"},{"key":"zoi250976r19","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199235339.001.0001","volume-title":"Oxford Handbook of Critical Care","author":"Singer","year":"2009"},{"key":"zoi250976r5","unstructured":"Statistics Canada. Most common prescription medications used in the past month, by age group and medication class, household population aged 3 to 19 years, Canada excluding the territories, 2012 to 2017. Updated March 17, 2021. Accessed November 15, 2024. https:\/\/www150.statcan.gc.ca\/n1\/pub\/82-003-x\/2021003\/article\/00001\/tbl\/tbl04-eng.htm"},{"key":"zoi250976r16","unstructured":"US Department of Health and Human Services. E2D(R1) post-approval safety data: definitions and standards for management and reporting of individual case safety reports. Published March 2024. Accessed August 26, 2025. https:\/\/www.fda.gov\/media\/176977\/download"},{"key":"zoi250976r23","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Medical Dictionary for Regulatory Activities (MedDRA). Accessed August 26, 2025. http:\/\/www.meddra.org"},{"key":"zoi250976r73","unstructured":"National Institute for Health and Care Excellence. Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management. Published March 19, 2024. Accessed August 26, 2025. https:\/\/www.nice.org.uk\/guidance\/ng240"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2839477\/lima_2025_oi_250976_1758638222.69696.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T15:30:43Z","timestamp":1759246243000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2839477"}},"subtitle":["A Systematic Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":75,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.34953","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]}}}